83. Addison disease
20 clinical trials,   42 drugs   (DrugBank: 13 drugs),   6 drug target genes,   17 drug target pathways
Searched query = "Addison disease", "Primary chronic adrenocortical insufficiency", "Autoimmune polyglandular syndrome", "Hypoparathyroidism-Addison-Monilia syndrome", "HAM syndrome", "Schmidt syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03210545 (ClinicalTrials.gov) | September 1, 2019 | 29/6/2017 | A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT) | A Dose-response Study of Markers of Glucocorticoid Effects (DOSCORT): A Single-blinded, Randomized, 2-dose, Cross-over Study | Addison Disease | Drug: Dexamethasone | Göteborg University | NULL | Unknown status | 20 Years | 60 Years | All | 30 | Phase 4 | Sweden |